PATENT CLAIM ANALYSIS

Application Number: 16100629
Application Type: Utility
Filing Date: 2018-08
Publication Date: 2018-12
Patent Classification: ["424", "009200"]

Abstract:
The concentration of an administered compound, such as a drug (D), in an organ or a bodily fluid, such as blood, is determined directly through detecting the drug (D) or its metabolites (DM) in sweat. The concentration may be determined indirectly by administering the drug (D) together with one or more tracer compounds (T, T2) or metabolites thereof (TM, T2M) or by detecting concentrations and trends of other analytes present in the body that react to the presence of the drug (D). By determining tracer concentration in sweat, the concentration of the drug (D) in blood or an organ can be determined. The tracer (T, T2) is a compound selected for ease of detection in sweat, known metabolic and solubility profiles that correspond to those of the drug (D), and safety of use. A smart transdermal delivery patch (300) is used to administer a dosage of drug to a wearer in coordination with at least one sweat sensor (324) reading conveying information about the wearer.

Claim (Index 4):
The method of  claim 1 , wherein at least one tracer compound is metabolized in a known rate correlated to said primary drug.

Metadata:
- Claim Count in Document: 13.0
- Percentile: 96.0
- Lexical Diversity: 2.21739
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15362303', '15382703', '15362229', '15362299', '14516974']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7083465408747968
- 35 USC 102 Novelty (BERT): 0.5207854204942242
- Combined Prediction Score: 0.6895904288367395
- Mean Citation Score: 127.298172
- Max Citation Score: 134.42775
- Similarity Product: 77.71542600484194

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test